CE-Ventures Backs Aptadir Therapeutics in €40 Million Seed Round, One of Europe’s Largest in Biotech
Aptadir raises €40 million in Italy’s largest biotech seed round and one of the largest in Europe Financing will advance a novel class of RNA inhibitor-based therapeutics, including lead candidate CAP1-FMR1 for Fragile X Syndrome Investment broadens CE-Ventures’ life sciences portfolio with an RNA therapeutics platform Dubai, United Arab Emirates,......
